NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT04929028 2026-03-18
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05643859 2026-01-15
Impact of Dietary Fiber Supplementation on Colonic Microbiome
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT04927897 2025-07-28
DETECT
Maastricht Radiation Oncology
Recruiting
NCT01887509 2018-05-15
TRaMA
IHU Strasbourg
Phase NA Terminated